Optical Visualization of Cathepsin K Activity in Atherosclerosis With a Novel, Protease-Activatable Fluorescence Sensor
Farouc A. Jaffer,Dong-Eog Kim,Luisa Quinti,Ching-Hsuan Tung,Elena Aikawa,Ashvin N. Pande,Rainer H. Kohler,Guo-Ping Shi,Peter Libby,Ralph Weissleder +9 more
278
TL;DR: Use of this novel protease-activatable NIRF agent for optical imaging in vivo demonstrated preferential localization of enzymatically active CatK to macrophages, consistent with their known greater elastinolytic capabilities compared with smooth muscle cells.
read more
Abstract: Background— Cathepsin K (CatK), a potent elastinolytic and collagenolytic cysteine protease, likely participates in the evolution and destabilization of atherosclerotic plaques. To assess better the biology of CatK activity in vivo, we developed a novel near-infrared fluorescence (NIRF) probe for imaging of CatK and evaluated it in mouse and human atherosclerosis. Methods and Results— The NIRF imaging agent consists of the CatK peptide substrate GHPGGPQGKC-NH2 linked to an activatable fluorogenic polymer. In vitro, CatK produced a 2- to 14-fold activation of the agent over other cysteine and matrix metalloproteinases (P 8-fold activation over a control imaging agent (P 100% NIRF signal increases in apolipoprotein E−/− mice in vivo (n=13; P<0.05, CatK imaging agent versus control agent) and in human carotid endarterectomy specimens ex vivo (n=14; P<0.05). Fluorescence microscopy of plaque sections demonstrated that enzymatically active Ca...
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Imaging of molecular probe activity with Born-normalized fluorescence optical projection tomography
Claudio Vinegoni,Paolo Fumene Feruglio,Virna Cortez-Retamozo,Daniel Razansky,Benjamin D. Medoff,Vasilis Ntziachristos,Andrea Sbarbati,Mikael J. Pittet,Ralph Weissleder +8 more
TL;DR: The possibility to achieve molecularly sensitive imaging contrast in optical projection tomography by means of targeted and activatable imaging reporter agents adds a new range of capabilities for investigating molecular signatures of pathophysiological processes and a wide variety of diseases and their development.
11
Cathepsin K-Activated Probe for Fluoro-Photoacoustic Imaging of Early Osteolytic Metastasis.
Zhuorun Song,Jia Miao,Minqian Miao,Shenhua Li,Yinghua Liu,Qing Qing Miao,Qing Li,Mingyuan Gao +7 more
TL;DR: In this article , a fluoro-photo-acoustic dual-modality imaging probe comprising a near-infrared dye caged by a cathepsin K (CTSK)-cleavable peptide sequence on one side and functionalized with osteophilic alendronate through a polyethylene glycol linker on the other side is reported.
11
Models and approaches to understand the role of airway remodelling in disease.
TL;DR: The integration of data from in vivo and in vitro models together with use of imaging techniques in man and animals should allow validation of models, further the understanding of the pathophysiology of airway remodelling and potentially improve predictive accuracy for the translation of novel therapeutic agents into the clinic.
11
Recent advances in visualizing vulnerable plaque: focus on noninvasive molecular imaging.
Gezim Bala,Bernard Cosyns +1 more
TL;DR: The rationale and fundamental principles of molecular imaging are highlighted, the promising imaging modalities, along with their potential limitations, and the molecular targets being investigated in experimental research are discussed.
9
Ultrasound guided fluorescence molecular tomography with improved quantification by an attenuation compensated Born-normalization and in vivo preclinical study of cancer.
TL;DR: An attenuation compensated Born-normalization method was developed to reduce the attenuation effects and cancel off experimental factors when collecting quantitative fluorescence datasets over large area and demonstrated that fluorescent targets could be recovered accurately and quantitatively using this reconstruction mechanism.
9
References
Compensatory Enlargement of Human Atherosclerotic Coronary Arteries
Seymour Glagov,Elliot Weisenberg,Christopher K. Zarins,Regina Stankunavicius,George J. Kolettis +4 more
TL;DR: It is concluded that human coronary arteries enlarge in relation to plaque area and that functionally important lumen stenosis may be delayed until the lesion occupies 40 percent of the internal elastic lamina area.
3.8K
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
Morteza Naghavi,Peter Libby,Erling Falk,S. Ward Casscells,S. Ward Casscells,Silvio H. Litovsky,Silvio H. Litovsky,John A. Rumberger,Juan J. Badimon,Christodoulos Stefanadis,Pedro R. Moreno,Gerard Pasterkamp,Zahi A. Fayad,Peter Stone,Sergio Waxman,Paolo Raggi,Mohammad Madjid,Mohammad Madjid,Alireza Zarrabi,Alireza Zarrabi,Allen P. Burke,Chun Yuan,Peter J. Fitzgerald,David S. Siscovick,Chris L. de Korte,Masanori Aikawa,K.E. Juhani Airaksinen,Gerd Assmann,Christoph R. Becker,James H. Chesebro,Andrew Farb,Zorina S. Galis,Christopher L. Jackson,Ik-Kyung Jang,Wolfgang Koenig,Robert A. Lodder,Keith L. March,Jasenka Demirovic,Mohamad Navab,Silvia G. Priori,Mark D. Rekhter,Raymond D. Bahr,Scott M. Grundy,Roxana Mehran,Antonio Colombo,Eric Boerwinkle,Christie M. Ballantyne,William Insull,Robert S. Schwartz,Robert A. Vogel,Patrick W. Serruys,Göran K. Hansson,David P. Faxon,Sanjay Kaul,Helmut Drexler,Philip Greenland,James E. Muller,Renu Virmani,Renu Virmani,Paul M. Ridker,Douglas P. Zipes,Prediman K. Shah,James T. Willerson,James T. Willerson +63 more
TL;DR: The term "vulnerable patient" may be more appropriate and is proposed now for the identification of subjects with high likelihood of developing cardiac events in the near future and a quantitative method for cumulative risk assessment of vulnerable patients needs to be developed.
Shedding light onto live molecular targets
TL;DR: Optical sensing of specific molecular targets and pathways deep inside living mice has become possible as a result of a number of advances, which will provide new tools making it possible to understand more fully the functioning of protein networks, diagnose disease earlier and speed along drug discovery.
2K
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes.
TL;DR: In vivo imaging showed a 12-fold increase in NIRF signal, allowing the detection of tumors with submillimeter-sized diameters, and this strategy can be used to detect such early stage tumors in vivo and to probe for specific enzyme activity.
1.7K
Pycnodysostosis, a Lysosomal Disease Caused by Cathepsin K Deficiency
TL;DR: It is suggested that cathepsin K is a major protease in bone resorption, providing a possible rationale for the treatment of disorders such as osteoporosis and certain forms of arthritis.
1K